Theravance Biopharma (TBPH) Ownership - Who Owns Theravance Biopharma?

353 Followers

Theravance Biopharma (TBPH) Ownership Overview

6.50% Insiders

9.66% Mutual Funds

1.12% Other Institutional Investors

13.35% ETFs

69.37% Public Companies and

Individual Investors

The ownership structure of Theravance Biopharma (TBPH) stock is a mix of institutional, retail, and individual investors. Approximately 24.13% of the company’s stock is owned by Institutional Investors, 6.50% is owned by Insiders, and 69.37% is owned by Public Companies and Individual Investors.

The ownership structure of Theravance Biopharma (TBPH) stock is a mix of institutional, retail, and individual investors. Approximately 10.78% of the company’s stock is owned by Institutional Investors, 6.50% is owned by Insiders, and 13.35% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Graham Capital Management, L.p.	xxxxxxxxxxxxx	$192638
Dec 31, 2023	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$646898

Show More Hedge Fund Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
2,142,421	Institution	4.16%	36,228,339
2,033,895	Institution	3.95%	34,393,164
1,767,061	Insider	3.43%	29,881,002
1,640,792	Institution	3.19%	27,745,793
626,349	Institution	1.22%	10,591,562
454,303	Institution	0.88%	7,682,264
431,557	Institution	0.84%	7,297,629
394,278	Institution	0.77%	6,667,241
391,381	Institution	0.76%	6,618,253
378,427	Institution	0.73%	6,399,201

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,640,792	Institution	3.19%	27,745,793
626,349	Institution	1.22%	10,591,562
454,303	Institution	0.88%	7,682,264
431,557	Institution	0.84%	7,297,629
378,427	Institution	0.73%	6,399,201
223,820	Institution	0.43%	3,784,796
223,457	Institution	0.43%	3,778,658
197,664	Institution	0.38%	3,342,498
116,715	Institution	0.23%	1,973,651
114,278	Institution	0.22%	1,932,441

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	1,324,682	Institution	2.57%	21,499,589
iShares Russell 2000 ETF	932,620	Institution	1.81%	15,770,604
Vanguard Extended Market ETF	413,967	Institution	0.80%	6,718,684
Invesco Dynamic Biotechnology & Genome ETF	366,332	Institution	0.71%	6,194,674
iShares Biotechnology ETF	353,168	Institution	0.69%	5,972,071
Pacer US Small Cap Cash Cows 100 ETF	290,162	Institution	0.56%	4,871,820
SPDR S&P Pharmaceuticals ETF	290,055	Institution	0.56%	4,904,830
iShares Russell 2000 Growth ETF	251,531	Institution	0.49%	4,253,389
Janus Henderson Small/Mid Cap Growth Alpha ETF	226,068	Institution	0.44%	3,795,682
Vanguard Russell 2000 ETF	188,725	Institution	0.37%	3,063,007

FAQ

Who Owns Theravance Biopharma (TBPH)?

According to the latest TipRanks data, approximately 1.12% of the company's stock is held by institutional investors, 6.50% is held by insiders, and 69.37% is held by retail investors.

What percentage of Theravance Biopharma (TBPH) stock is held by institutional investors?

According to the latest TipRanks data, approximately 1.12% of Theravance Biopharma (TBPH) stock is held by institutional investors.

What percentage of Theravance Biopharma (TBPH) stock is held by retail investors?

According to the latest TipRanks data, approximately 69.37% of Theravance Biopharma (TBPH) stock is held by retail investors.

Who owns the most shares of Theravance Biopharma (TBPH)?

Vanguard owns the most shares of Theravance Biopharma (TBPH).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.